Ozempic (semaglutide): Patients taking the 2.0 mg dose can lower their A1C up to 2.1% in some studies
If youve tried everything and your nausea, diarrhea, vomiting, or constipation havent improved, its time to reach out to your healthcare provider for help
At the class level, doseresponse meta-analyses further support nonlinear but predictable relationships between dose and weight loss across incretin-based therapies, with higher doses consistently associated with greater efficacy [7]
SELECT Trial The SELECT trial, one of the largest cardiovascular outcomes trials in obesity medicine, enrolled over 17,000 participants with established cardiovascular disease and obesity or overweight (without diabetes) and demonstrated a 20% reduction in MACE with semaglutide 2.4 mg
It should be taken subcutaneously once weekly, on the same day each week, at any time of day, with or without meals